Bloomberg: Curaleaf Enters Europe Cannabis Market in $285 Million Deal

Curaleaf Holdings Inc. agreed to buy Emmac Life Sciences Ltd. for about $285 million, giving the company entry into Europe’s rapidly growing cannabis market. Read more

Via: Bloomberg

Previous
Previous

CapStone Holdings Inc. Invests in United Green

Next
Next

STL Today: City Foundry developer stays upbeat amid latest hurdle, says opening planned midyear